...
首页> 外文期刊>International Journal of Pharmaceutics >Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator
【24h】

Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator

机译:使用流化床转子造粒机的高粘度水溶性聚合物在持续释放中空颗粒中进行较差的水溶性药物的制剂

获取原文
获取原文并翻译 | 示例
           

摘要

ater-soluble polymers with high viscosity are frequently used in the design of sustained-release formulations of poorly water-soluble drugs to enable complete release of the drug in the gastrointestinal tract. Tablets containing matrix granules with a water-soluble polymer are preferred because tablets are easier to handle and the multiple drug-release units of the matrix granules decreases the influences of the physiological environment on the drug. However, matrix granules with a particle size of over 800 mu m sometimes cause a content uniformity problem in the tableting process because of the large particle size. An effective method of manufacturing controlled-release matrix granules with a smaller particle size is desired. The aim of this study was to develop tablets containing matrix granules with a smaller size and good controlled-release properties, using phenytoin as a model poorly water-soluble drug. We adapted the recently developed hollow spherical granule granulation technology, using water-soluble polymers with different viscosities. The prepared granules had an average particle size of 300 mu m and sharp particle size distribution (relative width: 0.52-0.64). The values for the particle strength of the granules were 1.86-1.97 N/mm(2), and the dissolution profiles of the granules were not affected by the tableting process. The dissolution profiles and the blood concentration levels of drug released from the granules depended on the viscosity of the polymer contained in the granules. We succeeded in developing the desired controlled-release granules, and this study should be valuable in the development of sustained-release formulations of poorly water-soluble drugs.
机译:具有高粘度的ater-可溶性聚合物经常用于持续释放的水溶性药物的持续释放配方,以使药物在胃肠道中完全释放。含有水溶性聚合物的基质颗粒的片剂是优选的,因为片剂更容易处理,并且基质颗粒的多种药物释放单元降低了生理环境对药物的影响。然而,由于粒径大,具有超过800μm的粒度超过800μm的基质颗粒有时会导致压片过程中的含量均匀性问题。需要一种具有较小粒径的控制释放基质颗粒的有效方法。该研究的目的是开发含有较小尺寸和良好的控制释放性能的基质颗粒的片剂,使用苯妥汀作为模型不良水溶性药物。我们使用具有不同粘度的水溶性聚合物改编最近开发的空心球形颗粒造粒技术。制备的颗粒的平均粒径为300μm,粒度尺寸分布(相对宽度:0.52-0.64)。颗粒颗粒强度的值为1.86-1.97 n / mm(2),颗粒的溶解谱不受压片过程的影响。从颗粒中释放的药物的溶解曲线和血液浓度水平依赖于颗粒中含有的聚合物的粘度。我们成功地开发了所需的控释颗粒,并且该研究在持续释放的水溶性药物的持续释放配方的发展方面应该是有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号